Drug firm Dr Reddy's Laboratories will acquire select portfolio of established brands of Belgian firm UCB in India, Nepal, Sri Lanka and Maldives for Rs 800 crore (Rs 8 billion). The company has......
This includes seven products which are pending US Food and Drugs Administration approval (abbreviated new drug application) and an approved product spread across diverse dosage forms. Dr......